Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
An Sist Sanit Navar ; 41(1): 17-26, 2018 Apr 30.
Article in Spanish | MEDLINE | ID: mdl-29358784

ABSTRACT

BACKGROUND: Urinary tract infection (UTI) is a high prevalence infection at the community level. In order to improve the adequacy of the empirical therapy, we evaluated the etiology and the resistance pattern of the main uropathogens responsible for community acquired UTI in Navarre. METHODS: Retrospective study (2014-2016) in which we included microorganisms recovered with significant counts from samples of patients with community-acquired UTI. The global etiology and etiology according to age and sex was analyzed. Antimicrobial resistance was studied with urotopathogens isolated in 2016. RESULTS: Escherichia coli was the most frequently isolated microorganism both in the population (60.8%) and in each of the groups analyzed according to age and sex. The sensitivity of E. coli was: nitrofurantoin 97.4%, fosfomycin 96.5% amoxicillin-clavulanic acid 83.8%, trimethoprim-sulfamethoxazole 68.3%, quinolones 63.4% and amoxicillin 41.9%. Pooled sensitivity shows that the sensitivity to fosfomycin was 83.4% in men <15 years, 89.4% in women <15 years and 81.9% in women between 15-65 years; and to nitrofurantoin was 86.7% in women <15 years and 82.2% in women between 15-65 years. CONCLUSIONS: E. coli continues to be the most frequent microorganism in community-acquired UTI with a rate of sensitivity to fosfomycin and nitrofurantoin above 95%. The empirical treatment of UTI in our environment should not include amoxicillin, amoxicillin-clavulanic acid, trimethoprim-sulfamethoxazole or quinolones. Fosfomycin may be empirically used in the treatment of uncomplicated cystitis in men younger than 15 years and in women under 65 years, and nitrofurantoin may be used empirically in women under 65 years.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Urinary Tract Infections/microbiology , Adolescent , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Bacteria/isolation & purification , Community-Acquired Infections , Escherichia coli/drug effects , Escherichia coli/isolation & purification , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Retrospective Studies , Spain , Urinary Tract Infections/drug therapy , Young Adult
2.
Clin Microbiol Infect ; 15(11): 1013-9, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19673968

ABSTRACT

The present study evaluated changes in the incidence of invasive pneumococcal disease (IPD) and the pattern of serotypes isolated in Navarre, Spain, after the introduction and increased coverage of the heptavalent pneumococcal conjugate vaccine (PCV7). All cases with isolation of pneumococcus from normally sterile bodily fluids were included. The incidence of IPD in children and adults was compared for the periods 2001-2002 and 2006-2007. By the end of 2002, only 11% of children aged <5 years had received any dose of PCV7, whereas, beginning in 2007, the proportion exceeded 50%. Among the cases of IPD aged <5 years, the percentage of those vaccinated increased from 7% during 2001-2002 to 53% during 2006-2007 (p <0.001). The incidence of IPD from PCV7-serotypes decreased by 85% in children <5 years (p <0.001), by 45% in the population aged 5-64 years (p 0.10) and by 68% in those >or=65 years (p 0.004). By contrast, the incidence of IPD from non-PCV7 serotypes increased by 40% overall (p 0.006). The incidence of IPD from all serotypes did not change significantly in children <5 years (from 83 to 72 per 100 000) or in the total population (from 15.8 to 16.3 per 100 000). The percentage of cases as a result of serotypes 7 and 19A increased significantly in both children and adults. No significant changes were seen in the clinical forms of IPD. The pattern of serotypes causing IPD has changed, in both children and adults, following the increased coverage of PCV7, although the incidence has been reduced only slightly.


Subject(s)
Pneumococcal Infections/epidemiology , Pneumococcal Infections/microbiology , Pneumococcal Vaccines/immunology , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Bacterial Typing Techniques , Body Fluids/microbiology , Child , Child, Preschool , Female , Heptavalent Pneumococcal Conjugate Vaccine , Humans , Incidence , Infant , Infant, Newborn , Male , Middle Aged , Pneumococcal Infections/prevention & control , Serotyping , Spain/epidemiology , Young Adult
3.
An Sist Sanit Navar ; 27(2): 249-51, 2004.
Article in Spanish | MEDLINE | ID: mdl-15381958

ABSTRACT

Yersinia enterocolitica is a Gram-negative coccobacillus that is distributed world-wide and whose natural reservoir is found in a great variety of animals. Transmission to humans mainly occurs through the faecal-oral path although cases have been described of transmission through blood transfusions. It is isolated within a gastro-intestinal clinical picture and it rarely produces extra-intestinal disorders such as bacteraemia, abscesses, cutaneous signs, etc. The latter have been associated with different underlying diseases such as alterations of the iron metabolism, diabetes mellitus, alcoholism, malnutrition, tumours, immunosuppressant therapy and cirrhosis. We present the case of a diabetic patient who developed bacteraemia associated with hepatic abscess due to Yersinia enterocolitica.


Subject(s)
Bacteremia/microbiology , Liver Abscess/microbiology , Yersinia Infections/complications , Yersinia enterocolitica , Humans , Male , Middle Aged
4.
An Sist Sanit Navar ; 27(1): 21-5, 2004.
Article in Spanish | MEDLINE | ID: mdl-15146202

ABSTRACT

BACKGROUND: The aim of the present paper was to determine the prevalence and characteristics shown by isolations of Methicillin Resistant Staphylococcus Aureus, isolated in our Microbiology Service. METHODS: Retrospective study, covering the years 2000, 2001 and 2002. Analysis was made of the origin of the infection (nosocomial or non-nosocomial), the unit of origin in the event of nosocomial origin, anatomical localisation of the sample, and pattern of antibiotic sensitivity. RESULTS: The isolations of Methicillin Resistant Staphylococcus aureus accounted for 7.88% of the Staphylococcus aureus isolated. Less than half of the strains (44.87%) had a nosocomial origin and were most often isolated in the exudates of wounds. With respect to the pattern of resistance, there was some 50% of resistance to erythromycin, some 43.60% to clindamycine and some 21.79% to mupirocin. CONCLUSIONS: The prevalence and resistance pattern in vitro of the isolations of Methicillin Resistant Staphylococcus Aureus in our hospital are lower than that published in other areas of Spain.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Methicillin Resistance , Methicillin/therapeutic use , Staphylococcal Infections/epidemiology , Staphylococcus aureus/isolation & purification , Hospitals, University/statistics & numerical data , Humans , Microbial Sensitivity Tests , Prevalence , Retrospective Studies , Spain , Staphylococcal Infections/drug therapy , Staphylococcus aureus/drug effects
5.
An Sist Sanit Navar ; 27(1): 37-43, 2004.
Article in Spanish | MEDLINE | ID: mdl-15146204

ABSTRACT

The aims of present paper were to determine the susceptibility of the strains to the most usual antibiotics in clinical practice and to review the current recommendations to guide the most appropriate treatment. During the period october 2000 to september 2002, the patient's data (age and sex), source of the sample, diagnosis and antibiotic susceptibility were collected on Streptococcus pneumoniae isolates from microbiology laboratories in the Navarra region (555.829 inhabitants). Four hundred and sixty five isolates were identified (166 from invasive infections). Generally, isolates from ear swabs were the most resistant to the antimicrobials tested, while those from blood culture were the most susceptible. Of the Streptococcus pneumoniae tested, 43% were resistant to penicillin, 6.1% to amoxicillin and 6.6% to cefotaxime. Of the 36.3% of Streptococcus pneumoniae isolates that were resistant to erythromycin, 85.45% exhibited the MLSB phenotype while the remaining 14.55% presented with the M phenotype. Multiple-resistance was detected in 32.3% of the strains. The antibiotic resistance rates to beta-lactams (specially penicillin, amoxicillin and cefotaxime/ceftrixone) in Streptococcus pneumoniae don't prevent its clinical use for the most of Streptococcus pneumoniae isolated in our area, except for pneumococcal meningitis.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Pneumococcal Infections/drug therapy , Streptococcus pneumoniae/isolation & purification , Drug Resistance, Bacterial , Humans , Microbial Sensitivity Tests , Practice Guidelines as Topic , Serotyping , Spain , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/drug effects
6.
An. sist. sanit. Navar ; 27(2): 249-251, mayo 2004.
Article in Es | IBECS | ID: ibc-34531

ABSTRACT

Yersinia enterocolitica es un cocobacilo gram negativo de amplia distribución mundial cuyo reservorio natural se encuentra en una gran variedad de animales. La transmisión a los humanos se realiza principalmente a través de la vía fecal-oral aunque también se han descrito casos de transmisión a través de transfusiones sanguíneas. Su aislamiento se realiza habitualmente dentro de un cuadro gastrointestinal y rara vez produce trastornos extraintestinales como bacteriemia, abscesos, manifestaciones cutáneas, etc. Éstos se han asociado a diferentes enfermedades de base como alteraciones del metabolismo del hierro, diabetes mellitus, alcoholismo, malnutrición, tumores, terapia inmunosupresora y cirrosis. Presentamos el caso de un paciente diabético que desarrolló bacteriemia asociada a abscesso hepático por Yersinia enterocolitica (AU)


Subject(s)
Male , Middle Aged , Humans , Liver Abscess/diagnosis , Liver Abscess/therapy , Yersinia enterocolitica/isolation & purification , Yersinia enterocolitica/pathogenicity , Iron Metabolism Disorders/complications , Iron Metabolism Disorders/diagnosis , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/diagnosis , Skin Manifestations , Diabetes Mellitus/complications , Alcoholism/complications , Protein-Energy Malnutrition/complications , Immunosuppression Therapy/adverse effects , Fibrosis/complications
7.
An. sist. sanit. Navar ; 27(1): 21-25, ene. 2004. ilus
Article in Es | IBECS | ID: ibc-32190

ABSTRACT

Fundamento. El objetivo del presente trabajo ha sido conocer la prevalencia y características que presentan los aislamientos de Staphylococcus aureus resistentes a meticilina aislados en nuestro Servicio de Microbiología. Material y métodos. El estudio se desarrolló de forma retrospectiva abarcando los años 2000, 2001 y 2002. Se analizó el origen de la infección (nosocomial o extrahospitalaria), servicio de origen en caso de ser nosocomial, localización anatómica de la muestra y patrón de sensibilidad antibiótica. Resultados. Los aislamientos de Staphylococcus aureus resistentes a meticilina constituyeron el 7,88 por ciento de los Staphylococcus aureus aislados en nuestro servicio. Menos de la mitad de las cepas (44,87 por ciento) tuvieron un origen nosocomial y se aislaron con mayor frecuencia en los exudados de heridas. En cuanto al patrón de resistencia, hubo un 50 por ciento de resistencia a eritromicina, un 43,60 por ciento a clindamicina y un 21,79 por ciento a mupirocina. Conclusiones. La prevalencia y el patrón de resistencia in vitro de los aislamientos de Staphylococcus aureus resistentes a meticilina obtenidos en nuestro hospital es menor a la publicada en otras áreas de España (AU)


Subject(s)
Staphylococcus aureus/isolation & purification , Staphylococcus aureus/physiology , Methicillin Resistance/immunology , Methicillin Resistance/physiology , Cross Infection/complications , Cross Infection/diagnosis , Erythromycin/therapeutic use , Clindamycin/administration & dosage , Clindamycin/therapeutic use , Microbial Sensitivity Tests/methods , Microbial Sensitivity Tests , Retrospective Studies , Catalase/isolation & purification , Catalase/analysis , Mannitol/therapeutic use , Vancomycin/isolation & purification , Vancomycin/analysis , Teicoplanin/therapeutic use
8.
An. sist. sanit. Navar ; 26(3): 429-432, sept. 2003.
Article in Es | IBECS | ID: ibc-30311

ABSTRACT

La peritonitis bacteriana es una complicación frecuente en los pacientes cirróticos. De los gérmenes etiológicos, Aeromonas es muy poco frecuente. Presentamos un caso clínico de un paciente cirrótico con peritonitis y bacteriemia por Aeromonas hydrophila. Este microorganismo es un bacilo gramnegativo de la familia Vibrionaceae. En el ser humano produce gastroenteritis con mucha frecuencia. De forma excepcional puede dar origen a infecciones extraintestinales, sobre todo en pacientes inmunodeprimidos. La peritonitis por Aeromonas se ha descrito en asociación a peritonitis bacteriana espontánea en pacientes cirróticos, en pacientes en diálisis peritoneal y en casos de peritonitis secundaria a perforación intestinal (AU)


Subject(s)
Aged , Male , Humans , Peritonitis/complications , Aeromonas hydrophila/pathogenicity , Fibrosis , Liver Cirrhosis/complications , Hypertension, Portal/complications , Bacteremia/microbiology
9.
An Sist Sanit Navar ; 26(1): 27-33, 2003.
Article in Spanish | MEDLINE | ID: mdl-12759709

ABSTRACT

BACKGROUND: To determine in our hospital the sensitivity of isolations of Streptococcus pneumoniae to penicillin, as well as to analyse the association of resistance to penicillin and other antimicrobials and the activity of cefotaxime and cefepime in pencillin resistant strains of Streptococcus pneumoniae. METHODS: The sensitivity was determined on 103 isolations of Streptococcus pneumoniae, from clinical samples from the years 2000-2001, to penicillin, eritromycine, cloramfenicol, tetracycline, cotrimoxazol, cefotaxime, cefepime and levofloxacine. RESULTS: Sixty-eight percent of the isolations were sensitive to penicillin, while some 32% of the isolated strains of Streptococcus pneumoniae were penicillin resistant, with 7.7% showing a high degree of resistance. Resistance to eritromycine, cloramfenicol, tetracycline, cotrimoxazol and levofloxacine was 38.8%; 9.7%; 20.4%; 25.2% and 2.9% respectively, increasing to values of 66.6%; 30.3%; 48.5%; 72.7% and 9.1% in the 33 penicillin resistant strains. Resistance to cefotaxime and cefepime was 9.7% and 10.6% respectively. CONCLUSIONS. A high percentage of strains of Streptococcus pneumoniae show some degree of resistance to penicillin, but with lower figures than in other studies carried out at a national level. Similarly, it was demonstrated that resistance to penicillin is significantly associated (p < 0.001) with resistance to all the antimicrobials studied, except for levofloxacine. The resistances to cefotaxime and cefepime were comparable, with less activity being observed in these when facing penicillin resistant strains of Streptococcus pneumoniae.


Subject(s)
Anti-Bacterial Agents/pharmacology , Penicillin Resistance , Penicillins/pharmacology , Streptococcus pneumoniae/drug effects , Adult , Aged , Aged, 80 and over , Chloramphenicol/pharmacology , Erythromycin/pharmacology , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Ofloxacin/pharmacology , Pneumococcal Infections/drug therapy , Streptococcus pneumoniae/isolation & purification , Tetracycline/pharmacology , Trimethoprim, Sulfamethoxazole Drug Combination/pharmacology
10.
An Sist Sanit Navar ; 26(3): 429-31, 2003.
Article in Spanish | MEDLINE | ID: mdl-14716372

ABSTRACT

Bacterial peritonitis is a frequent complication in cirrhotic patients. Amongst the aetiological germs, Aeromonas is very infrequent. We present the clinical case of a cirrhotic patient with peritonitis and bacteraemia due to Aeromonas hydrophila. This micro-organism is a Gram-negative bacillus of the Vibrionaceae family. It very frequently produces gastroenteritis in the human being. Exceptionally it can give rise to extraintestinal infections, especially in immunodepressed patients. Peritonitis due to Aeromonas has been described in association with spontaneous bacterial peritonitis in cirrhotic patients, in patients on peritoneal dialysis and in cases of peritonitis secondary to intestinal perforation.


Subject(s)
Aeromonas hydrophila , Bacteremia/complications , Gram-Negative Bacterial Infections/complications , Liver Cirrhosis/complications , Peritonitis/complications , Aged , Gram-Negative Bacterial Infections/diagnosis , Humans , Male , Peritonitis/microbiology
14.
An. sist. sanit. Navar ; 23(supl.2): 69-80, mayo 2000. tab
Article in Es | IBECS | ID: ibc-22670

ABSTRACT

La utilización de antibióticos plantea problemas debido a la dificultad de elegir el adecuado entre la gran proliferación de productos existentes, lo que se traduce en un elevado porcentaje de utilización inadecuada ( entre un 31 y un 65 por ciento en estudios hospitalarios), y tiene como consecuencia -entre otras- la aparición de bacterias frente a las cuales apenas disponemos de antibióticos efectivos. Se revisa la problemática existente con determinados microorganismos: Staphylococus aureus resistentes a meticilina (MRSA) y con sensibilidad intermedia a glicopéptidos ( VISA, GISA), Enterococos resistentes a vancomicina (VRE), y otros gémenes multirresistentes, detallando las actuaciones a realizar para su prevención y control. Se recalca la importancia de dos factores que son susceptibles de modificación en la práctica clínica habitual: la utilización innecesaria de antibióticos que puede dar lugar a la aparición de cepas multirresistentes y limitar la propagación de dichas cepas ( mediante la adopción de las precauciones estándar y especialmente el lavado de las manos) (AU)


Subject(s)
Humans , Staphylococcus aureus , Enterococcus , Methicillin Resistance , Anti-Bacterial Agents/pharmacology , Staphylococcus aureus/pathogenicity , Enterococcus/pathogenicity , Staphylococcal Infections/drug therapy , Staphylococcal Infections/prevention & control , Hand Disinfection , Drug Resistance, Multiple , Clinical Protocols
18.
Enferm Infecc Microbiol Clin ; 12(9): 449-51, 1994 Nov.
Article in Spanish | MEDLINE | ID: mdl-7811772

ABSTRACT

BACKGROUND: The rate of processed blood cultures from anaerobic bottles was checked and the number of isolates from anaerobic microorganisms and other non anaerobic ones from processed bottles was established. Next, we studied the relationship between bacteremia caused by anaerobic organisms and the clinical history. METHODS: A total of 3.540 blood cultures have been checked for a period of 21 months; all of them were processed using Bactec NR 730 system. Those patients suffering bacteremia caused by anaerobic microorganisms had their medical histories revised. There is neither Gynecology nor Pediatrics Services at our Medical Center. RESULTS: Eleven episodes of bacteremias caused by anaerobic microorganisms have been detected since we started our research 21 months ago. Three aerobic microorganisms grew only in the two processed bottles in anaerobiosis, being their respective aerobic cultures negative. In all cases of bacteremia caused by anaerobic bacteria, the clinical history was compatible with this infection. CONCLUSIONS: We consider it is worth keeping the anaerobic bottles, because the number of anaerobic microorganisms isolates is considerable and clinically significant. A 2.76% incidence, where there is not gynecologist hospitalization, seems to be a high and relevant one. An alternative approach is to perform them only under certain clinical circumstances, although the process of collecting samples would make it a difficult task.


Subject(s)
Bacteria, Anaerobic/isolation & purification , Blood/microbiology , Bacteriological Techniques , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...